个人简历

Dr John Harvey came to Wales in 1993 to work with the University of Wales College of Medicine and North Wales Health Authority on the development of a medical academic unit in North Wales. Following the absorption of UWCM into Cardiff University Dr Harvey transferred to Bangor University in 2011. Dr Harvey is based in Wrexham and currently heads a research group of 10. Studies have been mainly in the areas of diabetes health psychology, diabetes epidemiology and diabetic complications particularly nephropathy. The lab team have been working on control of tropomyosin gene expression and its relationship to insulin, glucose and diabetes. John Harvey has published more than 80 papers. Dr Harvey’s clinical work includes general medicine and all aspects of diabetes together with provision of a specialist service for people on insulin pumps and all areas of endocrinology. Dr Harvey was Clinical Director for Medicine in Wrexham from 2003 to 2011 and has been a visiting professor at Glyndwr University since 2011.
2009: The Diabetes Research Network, Wales 2010-15 (coapplicant). Welsh Office of Research & Development £1,465,203.
2009: Self monitoring of blood glucose (SMBG): Comparison of no SMBG, SMBG alone, and SMBG with telecare. This study will be carried out in Cardiff (Prof DR Owens, lead applicant), Swansea (Prof S Bain) and Wrexham (Dr J Harvey) from 2010-12. European Federation for the Study of Diabetes 499,992euros.

近期论文

Harvey JN, Lawson VL. The importance of health belief models in determining self-care behaviour in diabetes. Diabetic Medicine 2009; 26: 5-13.
Lawson VL, Bundy C, Belcher J, Harvey JN. Mediation by illness perceptions of the effect of personality and health threat communication on coping with the diagnosis of diabetes. British Journal of Health Psychology 2010; 15: 623-642
O’Hagan M, Harvey JN. Glycaemic control in children with Type 1 diabetes in Wales: the influence of the Paediatric Diabetes Specialist Nurse. Diabetes Care 2010; 33: 1724-6
Savill SA, Leitch HF, Daly AK, Harvey JN, Thomas TH. Polymorphisms in the tropomyosin TPM1 short isoform promoter alter gene expression and are associated with increased risk of metabolic syndrome. American Journal of Hypertension 2010; 23: 399-404
Savill SA, Leitch HF, Harvey JN, Thomas TH. Functional Structure of the promoter regions for the predominant low molecular weight isoforms of tropomyosin in human kidney cells. Journal of Cellular Biochemistry 2012; 113: 3576-3586